GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
American Superconductor Corporation (AMSC) [hlAlert]

Rating:
Buy AMSC
down 24.70 %

American Superconductor Corporation (AMSC) rated Buy with price target $10 by Rodman & Renshaw

Posted on: Wednesday,  Jan 13, 2016  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Buy American Superconductor Corporation (NASDAQ: AMSC) on 01/13/2016, when the stock price was $5.99.
Since then, American Superconductor Corporation has lost 24.71% as of 01/13/2016's recent price of $4.51.
If you would have followed this Rodman & Renshaw's recommendation on AMSC, you would have lost 24.7% of your investment in 0 days.

American Superconductor Corporation is a leading energy technologies company. The company develops and sells a wide range of products and solutions based on power electronic systems and high temperature superconductor wires that dramatically improve the efficiency, reliability and quality of electricity during its generation, transmission, distribution and use. The company is a dominant force in alternative energy, offering grid interconnection solutions as well as licensed wind energy designs and electrical systems. As the world's principal supplier of HTS wire, AMSC is enabling a new generation of compact, high-power electrical products, including power cables, grid-level surge protectors, motors, generators, and advanced transportation and defense systems. AMSC also provides utility and industrial customers worldwide with voltage regulation systems that dramatically enhance power grid capacity, reliability and security, as well as industrial productivity.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/13/2016 8:25 AM Buy
None
5.99 10.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy